Today, PAXMAN publishes the September 2019 issue of its newsletter aimed at shareholders, investors and other interested parties.
This issue highlights PAXMAN’s upcoming launch in South Africa, where the company recently achieved market approval, and CEO Richard Paxman comments on the recently signed distribution agreement in Pakistan.
The newsletter also includes articles on the continued positive development in Oceania, the ongoing development of a prototype machine to prevent CIPN (nerve damage in hands and feet) together with National University Hospital, Singapore and three upcoming poster presentations at the ESMO conference in Barcelona on clinical studies where scalp cooling from PAXMAN was used.
Also, be sure to read PAXMAN’s interim report for the second quarter of 2019, which is now available in Swedish and English.
To read the newsletter, and subscribe to receive upcoming issues, follow this link:
PAXMAN’s investor newsletter is published monthly as a part of the company’s effort to strengthen its market communication together with the IR communication agency Honeybadger. Every published issue of the newsletter is available on PAXMANs website for investors, www.paxman.se. The company encourages feedback and requests on topics for upcoming issues of the newsletter.
